【ChiCTR1900023021】A study for the relationship between novel morphology parameters and embryo development for better selection of embryos undergoing in vitro fertilization
ChiCTR1900023021
正在进行
/
/
/
2019-05-07
/
/
不育症
A study for the relationship between novel morphology parameters and embryo development for better selection of embryos undergoing in vitro fertilization
A study for the relationship between novel morphology parameters and embryo development for better selection of embryos undergoing in vitro fertilization
This study aims to investigate the relationship between morphology parameters and embryo development to find out novel morphology predictors for better embryo selection for patients undergoing in vitro fertilization. The primary outcome of this study is to see whether the novel morphology parameters including cytoplasm size, zona pellucida grayscale, and embryo roundness can predict the blastocyst formation rate, implantation rate, pregnancy rate of embryos. The second outcome is whether those novel morphology parameters can predict the fertilization rate and the high-scoring embryo rate.
单臂
回顾性研究
N/A
N/A
无
/
120
/
2018-01-01
2020-12-31
/
Their images captured by routine practice will be used for a detail observation of novel morphology parameters. And the embryos development outcomes will be analyzed retrospectively with those parameters. There are no exclusion criteria for patient selection.;
请登录查看Their images captured by routine practice will be used for a detail observation of novel morphology parameters. And the embryos development outcomes will be analyzed retrospectively with those parameters. There are no exclusion criteria for patient selection.;
请登录查看香港中文大學
/
香港中文大學的其他临床试验
- 混合實境及沉浸式的神經認知眼科診斷 (MIND) 平台
- 青光眼中圖樣視網膜電圖之結構與功能整合
- 一种用于糖尿病视网膜病变定量病灶评估的眼动追踪注意感知强化学习算法
- 甲狀腺眼病患者外周免疫細胞譜
- 瞼板腺功能障礙的代謝組學研究
- Dissecting the role of gut microbiota in primary glaucoma patients through case-control and longitudinal cohort study
- 以理論為基礎的跨專業教育計劃,以提高香港華人社區長者的新冠疫苗接種率
- 復發性眼部單純疱疹病毒疾病患者的生活質素與病人自述結果:一項前瞻性橫斷面研究
- 正常眼壓青光眼疑似個案及視野缺損早期患者之眼壓藥物調整研究
- 使用生理和藥理方法調整眼瞼局部麻醉劑以改善手術止血效果和痛楚水平:雙盲隨機對照試驗
- Effects of nature-based mindfulness training on depression among adults with childhood adversity: A randomised controlled trial
- 一项关于合成益生菌制剂(SCM06)在儿童注意力缺陷多动障碍(ADHD)中疗效与安全性的预试验
- 网络心理支持平台对老年神经认知障碍和心理困扰护理人员的有效性研究
- Evaluation of the Effectiveness of the Enhanced 12-Session Caregiver Support Program - Shadowing the Golden Path 2.0
- 一项关于合生元配方 (MQU10) 在改善患有轻度至中度抑郁症状的成年人情绪和健康方面功效的初步研究
- 兒童阿托品抗藥性與近視發展機制之遺傳學研究
- 靜觀課程對有慢性壓力的長者的微生物群成效研究: 隨機對照試驗
- 懷舊干預措施對減少社區老年人孤獨感的影響:一項整群隨機等待名單對照試驗
- 智能眼科驅動的數字健康研究
- 成癮相關的眼科評估與管理(ADREAM)研究
香港中文大學婦產科學系的其他临床试验
- 經會陰超聲波量度胎頭位置之研究
- 该研究尚未获得伦理委员会批准。请于批准后才开始纳入参试者,并与我们联系上传批件。
- A study for the relationship between the microbiome and ART treatment outcomes
- A study for the relation among morphokinetic parameters, mitochondrial pattern and karyotype for better selection of embryos undergoing in vitro maturation
- A study for the relationship between novel morphology parameters and embryo development for better selection of embryos undergoing in vitro fertilization
- A pragmatic, multi-centre, three-arm randomised controlled trial to assess the clinical effectiveness and safety of time lapse imaging in in-vitro fertilisation treatment
- 生育狀況檢測問卷
- 身體活動對精子質素的影響
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 27
-
摩熵咨询 20 5
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 38
-
摩熵咨询 34 18
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29
